Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Drugs & Aging
|
July 31, 2008
Role of methotrexate in the treatment of bullous pemphigoid in the elderly
Timothy Patton, Neil Korman
Expert Opinion on Pharmacotherapy
|
November 18, 2006
Bullous pemphigoid treatment review
Timothy Patton, Neil J Korman
Drugs & Aging
|
September 19, 2009
Novel therapies for pemphigus vulgaris: an overview
Oliver A Perez, Timothy Patton
Antibiotics (Basel, Switzerland)
|
May 28, 2022
The Influence of Antibiotic Resistance on Innate Immune Responses to <i>Staphylococcus aureus</i> Infection
Nazneen Jahan, Timothy Patton, Meredith O'Keeffe
Dermatology Online Journal
|
April 22, 2009
Atypical histopathology in bowel-associated dermatosis-arthritis syndrome: A case report
Timothy Patton, Drazen Jukic, Elizabeth Juhas
Journal of the American Academy of Dermatology
|
August 7, 2021
COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence
Sarah Wack, Timothy Patton, Laura K Ferris
Cutis
|
December 13, 2017
Linear porokeratosis associated with multiple squamous cell carcinomas
Blake Friedman, Kseniya Golubets, Jonhan Ho, et al.
International Journal of Dermatology
|
January 24, 2008
The predominance of IgG4 in prodromal bullous pemphigoid
Philina M Lamb, Timothy Patton, Jau-Shyong Deng
Clinical and Experimental Dermatology
|
May 3, 2024
'You're speaking my language': an eczema case complicated by social determinants of health
Alice J Lin, Thomas K Le, Timothy Patton
Immunology and Cell Biology
|
April 23, 2026
From transcription to biological translation: regulation and recognition of MR1
Timothy Patton, Adam G Nelson, Alexandra J Corbett
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Drugs & Aging
|
July 31, 2008
Role of methotrexate in the treatment of bullous pemphigoid in the elderly
Timothy Patton, Neil Korman
Expert Opinion on Pharmacotherapy
|
November 18, 2006
Bullous pemphigoid treatment review
Timothy Patton, Neil J Korman
Drugs & Aging
|
September 19, 2009
Novel therapies for pemphigus vulgaris: an overview
Oliver A Perez, Timothy Patton
Antibiotics (Basel, Switzerland)
|
May 28, 2022
The Influence of Antibiotic Resistance on Innate Immune Responses to <i>Staphylococcus aureus</i> Infection
Nazneen Jahan, Timothy Patton, Meredith O'Keeffe
Dermatology Online Journal
|
April 22, 2009
Atypical histopathology in bowel-associated dermatosis-arthritis syndrome: A case report
Timothy Patton, Drazen Jukic, Elizabeth Juhas
Journal of the American Academy of Dermatology
|
August 7, 2021
COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence
Sarah Wack, Timothy Patton, Laura K Ferris
Cutis
|
December 13, 2017
Linear porokeratosis associated with multiple squamous cell carcinomas
Blake Friedman, Kseniya Golubets, Jonhan Ho, et al.
International Journal of Dermatology
|
January 24, 2008
The predominance of IgG4 in prodromal bullous pemphigoid
Philina M Lamb, Timothy Patton, Jau-Shyong Deng
Clinical and Experimental Dermatology
|
May 3, 2024
'You're speaking my language': an eczema case complicated by social determinants of health
Alice J Lin, Thomas K Le, Timothy Patton
Immunology and Cell Biology
|
April 23, 2026
From transcription to biological translation: regulation and recognition of MR1
Timothy Patton, Adam G Nelson, Alexandra J Corbett
Page
of 5